Science guides everything we do

Your brain is important to us

(We imagine it's pretty important to you, too)

Neuroscience research has uncovered how malleable the brain is, even for people with genetic markers for dementia and Alzheimer's disease. New scientific evidence reveals how targeted lifestyle changes can benefit brain health both now and in the future.

Neurotrack's clinically-validated cognitive health solutions are designed to help individuals assess, monitor, and strengthen their brain health over time.

The Science Behind Our Cognitive Assessments

Eye tracking reveals insights into cognitive function

Our eye-tracking technology uses the camera on your mobile device

Neurotrack's team of neuroscientists, neuropsychologists and engineers have developed a clinically-validated suite of cognitive assessments that leverage eye-tracking technology. These digital assessments, taken regularly and over time, can serve as an early detection tool for identifying cognitive changes early.

Our technology uses the groundbreaking research of renowned neuroscientist and Neurotrack's co-founder, Dr. Stuart Zola, whose breakthrough clinical study on Alzheimer's Disease showed that eye movements, tracked through a camera, reveal important data about the state of our cognitive health and its potential for decline in the future.

What do Neurotrack's assessments measure?


Our assessments measure multiple cognitive domains (and the brain has many!) and provide a detailed report of one's cognitive condition.

Processing Speed

The rate at which you take in new information, reach judgment on it, and formulate a response. For example, seeing a car run a light and responding by slamming on the brakes.

Recognition Memory

The ability to recognize previously encountered events, objects, or people. When you see a face at a coffee shop and remember it’s the guy who sat behind you in high school geometry, that’s recognition memory.

Associative Learning

The process of learning the link between items and concepts. Some examples are learning a new coworker's name, or learning that the sound of a siren means an emergency vehicle is near.

Associative Memory

Related to Associative Learning, this is the ability to remember the relationship between items. For example, smelling smoke and knowing that something must be burning on the stove, or walking down your street and knowing that this is where you live.

Inhibition

Your ability to control your thoughts and actions. For example, not looking at your phone while you are getting important work done, or stopping yourself from eating that second slice of chocolate cake.

Attention

Your ability to process information.

Examples include listening to your partner in a restaurant while ignoring everyone else (selective attention), watching a movie (sustained attention), talking to a passenger while driving (divided attention), or reading a recipe and cooking a meal (alternating attention).

Executive Function

Your ability to get tasks done. Planning a vacation, organizing household items, switching your thoughts from one task on your to-do list to another are all examples of executive function.

The Science Behind Our Cognitive Health Program

The FINGER Study

The FINGER study (The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) was a multi-year study of 1,200 adults at risk for cognitive decline. People who engaged in a multi-domain lifestyle intervention, including diet, exercise, and cognitive training, demonstrated improved cognitive performance.

This landmark study provides strong scientific evidence that targeted intervention can positively impact cognition over time – even in people who are at risk for decline. The FINGER study has been adapted on a global scale, with clinical studies taking place in multiple countries. Read more about World Wide FINGERS.

Overall Improvement

Executive Function

Processing Speed

The Neurotrack Cognitive Health Program

Our Cognitive Health Program is modeled after the multi-domain intervention that was proven to be effective in the FINGER study. Six lifestyle-related domains are included in our program, all of which are considered modifiable risk factors for dementia and Alzheimer's.

Stress management

Social engagement

Nutrition

Cognitive training

Sleep

Exercise

A year-long Phase 1 trial on the Neurotrack Cognitive Health Program demonstrated improvements in cognitive function, relief from depression, and a reduction in anxiety among older adults who were at-risk of cognitive impairment.

Neurotrack is always investing in its clinical research. In 2019, the company received a $3.3 million grant from the National Institute on Aging, a division of the U.S. National Institutes of Health, to conduct a Phase II randomized clinical trial to further validate Neurotrack’s Cognitive Health Program.

There is no cure, but you can reduce your risk


Currently, there is no cure for dementia-related diseases like Alzheimer's. Clinical trials in the past two decades have seen 146 failures with only 4 drugs approved for Alzheimer's treatment1. These FDA-approved drugs only treat the symptoms of the disease2. None of these drugs can slow or stop progression of the disease and symptoms often return over time.

So, what can you do?

It's not rocket science, but it is brain science. Neurotrack invests in and leverages the latest neuroscience research to deliver convenient, digital solutions to help businesses and individuals better manage their cognitive health for customers and themselves.

1. Stone, G. (2018). Researching Alzheimer’s medicines: Setbacks and stepping stones. Retrieved from Alzheimer’s Disease International website: https://www.alz.co.uk/sites/de...

2. Mayo Clinic. (2019, April 19). Alzheimer's: Drugs help manage symptoms. Retrieved from https://www.mayoclinic.org/dis...

We're dedicated to clinical research

2017 Bott

Webcam Validation


Frontiers in Neuroscience

This study validated the use of standard webcams in place of expensive research-grade eye tracking cameras for one of Neurotrack’s eye tracking tests. This data supports the scalability of Neurotrack’s tests, as no special equipment is required except a laptop, tablet, or smartphone with a webcam.

View

2018 Bott

30 Minute Test Validation


Journal of Medical Internet Research

This study demonstrated modest correlations between Neurotrack’s 30-minute eye tracking test and gold-standard cognitive assessments known to be sensitive to early signs of decline. The data supports the use of eye tracking tests that utilize device-embedded cameras to provide efficient and scalable evaluation of cognitive performance.

View

2018 Bott

Pilot Study Protocol


JMIR Research Protocols

This paper details the protocol and baseline characteristics of the participants in the VC Health study, a pilot study on the Cognitive Health Program. A total of 82 adults age 60-75 with subjective memory complaints enrolled in the year-long study and used the program.

View

2018 Kumar

Pilot Study Results


JMIR Aging

This paper details the results of the VC Health study, a pilot study on the Cognitive Health Program. Over 80 older adults with subjective memory decline enrolled in the study and were given access to the Cognitive Health Program. After one year, participants experienced significant improvements in cognitive function, anxiety, and depression.

View

2019 Bott

Scoring Algorithm Validation


Telemedicine and e-Health

This paper validates the use of Neurotrack’s proprietary algorithm for scoring eye tracking data. Study participants completed the Neurotrack 5-minute eye tracking test on 3 separate occasions while being simultaneously recorded by a webcam and a research-grade eye tracking camera. The data was equivalent across camera types and scoring modalities.

View

2019 Gills

5 Minute Test Validation


GeroScience

This paper demonstrates the stability and reliability of Neurotrack’s 5-minute eye tracking test. The test also correlates moderately with gold standard cognitive composites and Neurotrack’s 30-minute eye tracking test.

View

2019 McGurran

Exercise and AD Review


Journal of Alzheimer’s Disease

Exercise is known to be beneficial to the brain and cardiovascular system. This review paper summarizes what is currently known about the relationship between exercise and Alzheimer’s disease.

View

2019 Glenn

Protein and Amino Acid Maintenance


Nutrients

There is an abundant amount of proteins and amino acids in our regular diet, and regular consumption is linked to a number of disease-related risk factors for Alzheimer’s Disease and related dementias. This review by Neurotrack’s scientific team covers the preventative roles regular proteins and amino acids play, as well as makes recommendations on proper intake to decrease risk of cognitive decline.

View

2019 Glenn

Multimodal Digital Cognitive Health Platform in Japan


JMIR MHealth and UHealth

This paper details the cross-cultural feasibility of the Neurotrack platform in a Japanese population. Similar to previous literature, platform engagement metrics were highly correlated, with greater engagement shown to relate to increased participation in healthy lifestyle behaviors.

View

2019 Bott

Multidomain Interventions and Cognitive Health


Nutrients

The review presented here by Neurotrack’s scientific team covers completed and upcoming studies that use multi-domain lifestyle interventions to promote cognitive health and decrease the risk of Alzheimer’s Disease and related dementias. These include the upcoming World-Wide FINGERS studies and a number of studies supported by digital intervention strategies.

View

Inclusivity Research Initiative

Join Neurotrack in addressing the gap that exists in Alzheimer’s research today. We are offering an opportunity to researchers to use Neurotrack's digital cognitive assessment platform in dementia and Alzheimer's studies involving underrepresented populations. The application period is open through February 21, 2021.

Learn more